Who are we?

Our vaccine business is divided in to two sections:

1) Research and Development (R&D) to invent new vaccines technologies that ensure safe and effective delivery of vaccines to protect against diseases and hence limit the economic losses; 

2) Autogenous vaccine (custom-made vaccine) support to help our clients protecting their turkey and chicken flocks against emerging diseases. 

1- Reovirus vaccines

- Aviaxin starts to support avian reovirus autogenous vaccine service. By using a unique typing scheme of reovirus isolates, our customers will be able to take the right decision of reovirus autogenous vaccination. Within a short timeline, our customers will obtain their vaccines. They can also track the laboratory diagnostic process, typing and manufacturing through Aviaxin App (will be available soon).

 Will be released soon 

 - Aviaxin will soon offer avian reovirus diagnostic services including histopathology, virus isolation, serology, RT-PCR and sequencing. See the submission instruction guide for avian reovirus. 

 - Aviaxin is initiating R&D projects to detect the genetic determinants of pathogenicity and serogrouping of chicken and turkey reoviruses and to produce novel reovirus vaccines. Sending your isolates to Aviaxin diagnostic laboratory will support the future progress of the diagnostic process, the typing of avian reoviruses and the production of safe effective vaccines that support poultry production.  

Coming Soon